Maria M Araneta, PA-C | |
18101 Prince Philip Dr, Olney, MD 20832-1514 | |
(301) 774-8610 | |
Not Available |
Full Name | Maria M Araneta |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 18101 Prince Philip Dr, Olney, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124556857 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | C06456 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Maria M Araneta, PA-C 5314 Residencia, Newport Beach, CA 92660-9045 Ph: (240) 401-9033 | Maria M Araneta, PA-C 18101 Prince Philip Dr, Olney, MD 20832-1514 Ph: (301) 774-8610 |
News Archive
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that it has again been selected to be part of the Dow Jones Sustainability World Indexes and North America Indexes (DJSI World and DJSI North America). The company is in its seventh year on the World Index (since 2004) and in its sixth on the North American Index (since 2005).
Researchers at the Oregon Health & Science University School of Dentistry have determined that ATP-driven (adenosine triphosphate-driven) bioluminescence - a way of measuring visible light generated from ATP contained in bacteria - is an innovative tool for rapidly assessing in children at the chair-side the number of oral bacteria and amount of plaque that can ultimately lead to tooth decay.
CorMatrix Cardiovascular, Inc., a medical device company developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that FDA has granted conditional approval for the start of a multi-center, prospective, randomized clinical trial to demonstrate the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation.
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way - by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because preventing the development of these "feet" also eliminates the action of proteins present in the feet that burn through intact tissue and let cancer cells enter new cells.
› Verified 5 days ago
Shawn Chong, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 18109 Prince Philip Dr, Suite 300, Olney, MD 20832 Phone: 301-570-8554 | |
Paul Andrew Burke, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Montgomery General Hospital, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8574 | |
Ms. Letha Menon Sunil, PA - C Physician Assistant Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8882 | |
Mr. Ronald L Swaim, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 3414 Olandwood Ct, Olney, MD 20832 Phone: 301-774-0500 | |
Nicole Prince Davis, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 18101 Prince Philip Drive, Olney, MD 20832 Phone: 301-774-8900 Fax: 301-570-8571 | |
Maria Elena Marcos Espina, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 18109 Prince Philip Dr, Suite 300, Olney, MD 20832 Phone: 301-570-7203 Fax: 301-570-8556 |